Mutation analysis of the PALB2 cancer predisposition gene in familial melanoma
Authors:
- 11 December 2010
- journal article
- research article
- Published by Springer Nature in Familial Cancer
- Vol. 10 (2) , 315-317
Abstract
PALB2 is a breast and pancreas cancer susceptibility gene whose protein is closely associated with BRCA2 and is essential for BRCA2 anchorage to nuclear structures. This functional relationship made PALB2 a candidate gene for susceptibility to BRCA2-related cancers such as melanoma. The purpose of this study was to screen for the presence of germline mutations in PALB2 in familial melanoma cases. We sequenced the exons and intron–exon boundaries of PALB2 in probands from 53 families with familial melanoma where CDKN2A mutations were absent. A number of previously reported coding and non-coding variants were observed. However, no truncating mutations were identified. These results indicate that deleterious PALB2 mutations are unlikely to play a significant role in familial melanoma.Keywords
This publication has 10 references indexed in Scilit:
- PALB2/FANCN: Recombining Cancer and Fanconi AnemiaCancer Research, 2010
- BRCA1 and BRCA2 families and the risk of skin cancerFamilial Cancer, 2010
- Genetic risk factors for melanomaHuman Genetics, 2009
- Analysis ofPALB2/FANCN-associated breast cancer familiesProceedings of the National Academy of Sciences, 2007
- PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility geneNature Genetics, 2006
- High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMELCancer Research, 2006
- Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2Molecular Cell, 2006
- BRCA1 and BRCA2: 1994 and beyondNature Reviews Cancer, 2004
- Cancer Risks in BRCA2 Mutation CarriersJNCI: Journal of the National Cancer Institute, 1999
- Germline p16 mutations in familial melanomaNature Genetics, 1994